Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
- PMID: 30430043
- PMCID: PMC6231424
- DOI: 10.7717/peerj.5931
Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
Abstract
Background: Cystic fibrosis (CF) is a disease characterized by chronic airway infection with a high incidence and poor prognosis. Pseudomonas aeruginosa and Aspergillus fumigatus are pathogens commonly found in CF patients. Clinically, these two microorganisms often coexist in the airway of CF patients. Combined infection with P. aeruginosa and A. fumigatus results in worsening lung function and clinical condition.
Methods: In this review, we focus on the mutual inhibition and promotion mechanisms of P. aeruginosa and A. fumigatus in CF patients. We also summarized the mechanisms of the interaction between these pathogenic microorganisms.
Results: P. aeruginosa inhibits A. fumigatus growth through the effects of phenazines, the quorum sensing system, iron competition, bacteriophages, and small colony variants. P. aeruginosa induces A. fumigatus growth through volatile organic compounds and subbacteriostatic concentrations of phenazines. A. fumigatus interferes with P. aeruginosa, affecting its metabolic growth via phenazine metabolic transformation, gliotoxin production, and reduced antibiotic sensitivity.
Discussion: Coexistence of P. aeruginosa and A. fumigatus can lead to both mutual inhibition and promotion. In different stages of CF disease, the interaction between these two pathogenic microorganisms may shift between promotion and inhibition. A discussion of the mechanisms of P. aeruginosa and A. fumigatus interaction can be beneficial for further treatment of CF patients and for improving the prognosis of the disease.
Keywords: Aspergillus fumigatus; Cystic fibrosis; Infection; Intermicrobial interaction; Pseudomonas aeruginosa.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis.Eur Respir Rev. 2020 Nov 18;29(158):200011. doi: 10.1183/16000617.0011-2020. Print 2020 Dec 31. Eur Respir Rev. 2020. PMID: 33208485 Free PMC article. Review.
-
Secondary Metabolites Produced during Aspergillus fumigatus and Pseudomonas aeruginosa Biofilm Formation.mBio. 2022 Aug 30;13(4):e0185022. doi: 10.1128/mbio.01850-22. Epub 2022 Jul 20. mBio. 2022. PMID: 35856657 Free PMC article.
-
Under nonlimiting iron conditions pyocyanin is a major antifungal molecule, and differences between prototypic Pseudomonas aeruginosa strains.Med Mycol. 2021 May 4;59(5):453-464. doi: 10.1093/mmy/myaa066. Med Mycol. 2021. PMID: 32827431
-
Aspergillus fumigatus Inhibits Pseudomonas aeruginosa in Co-culture: Implications of a Mutually Antagonistic Relationship on Virulence and Inflammation in the CF Airway.Front Microbiol. 2018 Jun 5;9:1205. doi: 10.3389/fmicb.2018.01205. eCollection 2018. Front Microbiol. 2018. PMID: 29922270 Free PMC article.
-
The co-colonization prevalence of Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis: A systematic review and meta-analysis.Microb Pathog. 2018 Dec;125:122-128. doi: 10.1016/j.micpath.2018.09.010. Epub 2018 Sep 11. Microb Pathog. 2018. PMID: 30217514
Cited by
-
Molecular Modifications of the Pseudomonas Quinolone Signal in the Intermicrobial Competition with Aspergillus.J Fungi (Basel). 2021 Apr 28;7(5):343. doi: 10.3390/jof7050343. J Fungi (Basel). 2021. PMID: 33925067 Free PMC article.
-
Phenazine-1-Carboxylic Acid (PCA), Produced for the First Time as an Antifungal Metabolite by Truncatella angustata, a Causal Agent of Grapevine Trunk Diseases (GTDs) in Iran.J Agric Food Chem. 2021 Oct 20;69(41):12143-12147. doi: 10.1021/acs.jafc.1c03877. Epub 2021 Oct 8. J Agric Food Chem. 2021. PMID: 34623150 Free PMC article.
-
The Expanding Mycovirome of Aspergilli.J Fungi (Basel). 2024 Aug 17;10(8):585. doi: 10.3390/jof10080585. J Fungi (Basel). 2024. PMID: 39194910 Free PMC article. Review.
-
Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.Front Med (Lausanne). 2022 Mar 21;9:832510. doi: 10.3389/fmed.2022.832510. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35386908 Free PMC article. Review.
-
Fungal Infection and Inflammation in Cystic Fibrosis.Pathogens. 2021 May 18;10(5):618. doi: 10.3390/pathogens10050618. Pathogens. 2021. PMID: 34069863 Free PMC article. Review.
References
-
- Al-Momani H, Perry A, Stewart CJ, Jones R, Krishnan A, Robertson AG, Bourke S, Doe S, Cummings SP, Anderson A, Forrest T, Griffin SM, Brodlie M, Pearson J, Ward C. Microbiological profiles of sputum and gastric juice aspirates in cystic fibrosis patients. Scientific Reports. 2016;6(1):26985. doi: 10.1038/srep26985. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources